Exhibit 32.1


                 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
                 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
                       THE SARBANES-OXLEY ACT OF 2002


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each
of the undersigned officers of KV Pharmaceutical Company, a Delaware
corporation (the "Company"), does hereby certify that, to the best of their
knowledge:

The Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 (the
"Form 10-Q") of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of the Company.

Date: August 14, 2003        /s/ Marc S. Hermelin
                             ---------------------------------------------
                             Marc S. Hermelin
                             Vice Chairman and Chief Executive Officer

Date: August 14, 2003        /s/ Gerald R. Mitchell
                             ---------------------------------------------
                             Gerald R. Mitchell
                             Vice President, Treasurer and Chief Financial
                             Officer

A signed original of this written statement required by Section 906 has been
provided to KV Pharmaceutical Company and will be retained by KV
Pharmaceutical Company and furnished to the Securities and Exchange
Commission or its staff upon request.